(KER) Kering - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000121485
Fashion, Leather, Jewelry, Eyewear, Fragrances
Dividends
| Dividend Yield | 2.34% |
| Yield on Cost 5y | 1.52% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 95.8% |
| Payout Ratio | 82.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 35.6% |
| Value at Risk 5%th | 50.1% |
| Relative Tail Risk | -14.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 30.31 |
| CAGR/Max DD | -0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.449 |
| Beta | 0.152 |
| Beta Downside | 0.576 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.00% |
| Mean DD | 39.88% |
| Median DD | 42.75% |
Description: KER Kering December 11, 2025
Kering SA (ticker KER) is a Paris-based luxury conglomerate that designs, manufactures, and distributes ready-to-wear, accessories, leather goods, footwear, watches, jewelry, eyewear, and beauty products across major markets including Asia-Pacific, Western Europe, North America, and Japan. Its portfolio comprises high-profile houses such as Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Brioni, Boucheron, Pomellato, DoDo, Qeelin, Ginori 1735, as well as the Kering Eyewear and Kering Beauté divisions.
In FY 2023 Kering reported €19.9 billion in revenue, with an operating margin of 22.4 % and a 12 % year-over-year increase in Asia-Pacific sales, reflecting strong post-pandemic demand for luxury goods in China and emerging markets. The luxury sector’s growth is currently driven by rising high-net-worth consumer spending, a shift toward experiential purchases, and resilient discretionary demand despite macro-economic headwinds such as inflation and tighter credit conditions.
For a deeper quantitative assessment, the ValueRay platform offers granular metrics and scenario analysis to help you evaluate Kering’s valuation under different growth assumptions.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.81b TTM) > 0 and > 6% of Revenue (6% = 2.05b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.09% (prev 11.59%; Δ -3.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 7.10b > Net Income 2.81b (YES >=105%, WARN >=100%) |
| Net Debt (15.65b) to EBITDA (9.63b) ratio: 1.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (122.7m) change vs 12m ago 0.27% (target <= -2.0% for YES) |
| Gross Margin 74.29% (prev 75.21%; Δ -0.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 88.40% (prev 87.17%; Δ 1.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.70 (EBITDA TTM 9.63b / Interest Expense TTM 1.18b) >= 6 (WARN >= 3) |
Altman Z'' 3.71
| (A) 0.07 = (Total Current Assets 11.33b - Total Current Liabilities 8.56b) / Total Assets 42.43b |
| (B) 0.35 = Retained Earnings (Balance) 14.90b / Total Assets 42.43b |
| (C) 0.14 = EBIT TTM 5.53b / Avg Total Assets 38.70b |
| (D) 1.12 = Book Value of Equity 30.03b / Total Liabilities 26.82b |
| Total Rating: 3.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.49
| 1. Piotroski 5.50pt |
| 2. FCF Yield 6.50% |
| 3. FCF Margin 10.17% |
| 4. Debt/Equity 1.35 |
| 5. Debt/Ebitda 1.62 |
| 6. ROIC - WACC (= 9.58)% |
| 7. RoE 18.77% |
| 8. Rev. Trend 8.52% |
| 9. EPS Trend -27.43% |
What is the price of KER shares?
As of December 19, 2025, the stock is trading at EUR 310.30 with a total of 300,222 shares traded.
Over the past week, the price has changed by +6.32%, over one month by +0.16%, over three months by +15.46% and over the past year by +34.93%.
Over the past week, the price has changed by +6.32%, over one month by +0.16%, over three months by +15.46% and over the past year by +34.93%.
Is KER a buy, sell or hold?
Kering has no consensus analysts rating.
What are the forecasts/targets for the KER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 294 | -5.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 294.5 | -5.1% |
KER Fundamental Data Overview December 12, 2025
Market Cap USD = 42.02b (35.79b EUR * 1.1742 EUR.USD)
Market Cap EUR = 35.79b (35.79b EUR * 1.0 EUR.EUR)
P/E Trailing = 49.0504
P/E Forward = 29.8507
P/S = 2.2703
P/B = 2.3978
P/EG = 2.1944
Beta = 1.17
Revenue TTM = 34.21b EUR
EBIT TTM = 5.53b EUR
EBITDA TTM = 9.63b EUR
Long Term Debt = 10.57b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.01b EUR (from shortTermDebt, last quarter)
Debt = 19.89b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.65b EUR (from netDebt column, last quarter)
Enterprise Value = 53.54b EUR (35.79b + Debt 19.89b - CCE 2.13b)
Interest Coverage Ratio = 4.70 (Ebit TTM 5.53b / Interest Expense TTM 1.18b)
FCF Yield = 6.50% (FCF TTM 3.48b / Enterprise Value 53.54b)
FCF Margin = 10.17% (FCF TTM 3.48b / Revenue TTM 34.21b)
Net Margin = 8.20% (Net Income TTM 2.81b / Revenue TTM 34.21b)
Gross Margin = 74.29% ((Revenue TTM 34.21b - Cost of Revenue TTM 8.79b) / Revenue TTM)
Gross Margin QoQ = 73.01% (prev 73.06%)
Tobins Q-Ratio = 1.26 (Enterprise Value 53.54b / Total Assets 42.43b)
Interest Expense / Debt = 1.60% (Interest Expense 319.0m / Debt 19.89b)
Taxrate = 27.56% (199.0m / 722.0m)
NOPAT = 4.01b (EBIT 5.53b * (1 - 27.56%))
Current Ratio = 1.32 (Total Current Assets 11.33b / Total Current Liabilities 8.56b)
Debt / Equity = 1.35 (Debt 19.89b / totalStockholderEquity, last quarter 14.77b)
Debt / EBITDA = 1.62 (Net Debt 15.65b / EBITDA 9.63b)
Debt / FCF = 4.50 (Net Debt 15.65b / FCF TTM 3.48b)
Total Stockholder Equity = 14.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.61% (Net Income 2.81b / Total Assets 42.43b)
RoE = 18.77% (Net Income TTM 2.81b / Total Stockholder Equity 14.95b)
RoCE = 21.68% (EBIT 5.53b / Capital Employed (Equity 14.95b + L.T.Debt 10.57b))
RoIC = 14.22% (NOPAT 4.01b / Invested Capital 28.18b)
WACC = 4.64% (E(35.79b)/V(55.67b) * Re(6.57%) + D(19.89b)/V(55.67b) * Rd(1.60%) * (1-Tc(0.28)))
Discount Rate = 6.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.09%
[DCF Debug] Terminal Value 74.43% ; FCFE base≈3.59b ; Y1≈2.85b ; Y5≈1.90b
Fair Price DCF = 289.0 (DCF Value 35.44b / Shares Outstanding 122.6m; 5y FCF grow -24.62% → 3.0% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.52 | Revenue CAGR: -0.78% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=8.48 | Chg30d=-0.024 | Revisions Net=-1 | Growth EPS=+40.1% | Growth Revenue=+2.6%
Market Cap EUR = 35.79b (35.79b EUR * 1.0 EUR.EUR)
P/E Trailing = 49.0504
P/E Forward = 29.8507
P/S = 2.2703
P/B = 2.3978
P/EG = 2.1944
Beta = 1.17
Revenue TTM = 34.21b EUR
EBIT TTM = 5.53b EUR
EBITDA TTM = 9.63b EUR
Long Term Debt = 10.57b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.01b EUR (from shortTermDebt, last quarter)
Debt = 19.89b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.65b EUR (from netDebt column, last quarter)
Enterprise Value = 53.54b EUR (35.79b + Debt 19.89b - CCE 2.13b)
Interest Coverage Ratio = 4.70 (Ebit TTM 5.53b / Interest Expense TTM 1.18b)
FCF Yield = 6.50% (FCF TTM 3.48b / Enterprise Value 53.54b)
FCF Margin = 10.17% (FCF TTM 3.48b / Revenue TTM 34.21b)
Net Margin = 8.20% (Net Income TTM 2.81b / Revenue TTM 34.21b)
Gross Margin = 74.29% ((Revenue TTM 34.21b - Cost of Revenue TTM 8.79b) / Revenue TTM)
Gross Margin QoQ = 73.01% (prev 73.06%)
Tobins Q-Ratio = 1.26 (Enterprise Value 53.54b / Total Assets 42.43b)
Interest Expense / Debt = 1.60% (Interest Expense 319.0m / Debt 19.89b)
Taxrate = 27.56% (199.0m / 722.0m)
NOPAT = 4.01b (EBIT 5.53b * (1 - 27.56%))
Current Ratio = 1.32 (Total Current Assets 11.33b / Total Current Liabilities 8.56b)
Debt / Equity = 1.35 (Debt 19.89b / totalStockholderEquity, last quarter 14.77b)
Debt / EBITDA = 1.62 (Net Debt 15.65b / EBITDA 9.63b)
Debt / FCF = 4.50 (Net Debt 15.65b / FCF TTM 3.48b)
Total Stockholder Equity = 14.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.61% (Net Income 2.81b / Total Assets 42.43b)
RoE = 18.77% (Net Income TTM 2.81b / Total Stockholder Equity 14.95b)
RoCE = 21.68% (EBIT 5.53b / Capital Employed (Equity 14.95b + L.T.Debt 10.57b))
RoIC = 14.22% (NOPAT 4.01b / Invested Capital 28.18b)
WACC = 4.64% (E(35.79b)/V(55.67b) * Re(6.57%) + D(19.89b)/V(55.67b) * Rd(1.60%) * (1-Tc(0.28)))
Discount Rate = 6.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.09%
[DCF Debug] Terminal Value 74.43% ; FCFE base≈3.59b ; Y1≈2.85b ; Y5≈1.90b
Fair Price DCF = 289.0 (DCF Value 35.44b / Shares Outstanding 122.6m; 5y FCF grow -24.62% → 3.0% )
EPS Correlation: -27.43 | EPS CAGR: -69.17% | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.52 | Revenue CAGR: -0.78% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=8.48 | Chg30d=-0.024 | Revisions Net=-1 | Growth EPS=+40.1% | Growth Revenue=+2.6%